Shield tests make cancer screening more accessible
Philip Vonada
South Williamsport
Losing family to cancer changed my outlook on life. It taught me that when it comes to cancer, putting off screening just isn’t worth the risk.
With Colorectal Cancer Awareness Month around the corner, I hope people across Pennsylvania will take a moment to consider the importance of prevention for this disease that is estimated to claim more than 2,000 Pennsylvanian lives this year alone – more than one in three Pennsylvanians diagnosed with colorectal cancer die from the disease.
The problem is that people are not getting screened on time. Nearly 30 percent of Pennsylvanians aged 45-75 aren’t up to date on their screenings. These numbers hit home for me, and they’re a reminder that too many families are still facing heartbreak from a disease that is easily treated when caught early.
I know many people put off getting screened because colonoscopies are uncomfortable and a hassle to plan around, but things have changed. There’s now a blood test called Shield, the first and only FDA-approved blood test as a primary screening option for adults 45 and older at average risk. It’s just a quick blood draw at your regular doctor’s visit. That blood draw could potentially save your life.
No family should have to go through cancer loss if it can be prevented. Talk to your doctor, ask about your screening options, and make it a priority. Taking care of your health is one of the easiest ways to care for yourself and the people you love.
Philip Vonada is Vice President of the Pennsylvania State Grange.
